Project Grant 2507703
- Neurotechr3 Inc. received a $276,000 STTR Phase I Project Grant award from the National Science Foundation on May 1, 2021 to develop a customized upper extremity telerehabilitation solution. The solution will feature remote therapist interaction and dynamic motor recovery feedback for stroke patients. The award is funded under the NSF Directorate for Engineering's Engineering program (CFDA 47.041) to improve quality of life and economic strength through innovative engineering research and...
- Federal Grant Award Summary Hominin.ai Inc. received a $302,668 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on August 1, 2025, for a twelve-month performance period concluding July 31, 2026. The company will develop a software system and machine learning models that translate ordinary human walking patterns into movement-based biomarkers of personal health using...
- Federal Grant Award Summary Afference Inc. received a $305,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) effective July 15, 2025, with completion targeted for June 30, 2026. The company is developing neural haptics technology—a novel wearable interface solution that uses peripheral nerve stimulation to create artificial sensations of touch in consumer electronics. This...
- Federal Grant Award Summary Feel With Me LLC received $187,378 in Phase I Small Business Technology Transfer (STTR) funding from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), with performance commencing October 1, 2025 and concluding September 30, 2026. The awardee, located in Tallahassee, Florida, will develop flexible sensor arrays utilizing carbon nanotube buckypaper (CNT-BP) technology integrated with ink-jet printing processes to...
- Federal Project Grant Award Summary The National Science Foundation's Directorate for Engineering (CFDA 47.041) awarded William Marsh Rice University $450,000 on March 1, 2026, for a three-year project (completion date: February 28, 2029) to develop self-optimizing electrical muscle stimulation (EMS) garments for rehabilitation of nervous system injuries, including spinal cord injury and stroke. The project delivers an integrated wearable device and real-time machine learning-based control...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Smartcharts Inc. aims to develop a software platform that streamlines rehabilitation documentation and patient progress tracking. The proposed "SmartCharts" innovation utilizes machine learning and data visualization to standardize rehabilitation documentation, create personalized patient progress reports, and improve communication between care teams and...
- Federal Project Grant Award Summary AMG Detection, Inc. received a $305,000 Small Business Technology Transfer (STTR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 1, 2026 through June 30, 2027. The company is developing a wearable carbon nanotube sensor array designed to predict epileptic seizures 10–45 minutes before onset by detecting nine pre-seizure volatile organic compounds (VOCs)...
- This $750,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will fund the development of appropriate rehabilitation technology for stroke survivors through passive tactile stimulation. The Leland Stanford Junior University will lead an interdisciplinary team including universities, hospitals, and community organizations to finalize the team composition, generate use cases, and develop a comprehensive research plan including initial...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Rehabnetics Medical LLC will fund the development of a prototype robotic wrist-hand exoskeleton device for physical therapy. The system aims to provide tailored rehabilitative exercises and quantified measures of therapeutic progress for patients with motor deficits resulting from neurological conditions such as stroke, traumatic brain injury, and Parkinson's...
- Federal Project Grant Award Summary Pison Technology, Inc. received a $459,097 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, with an award date of June 12, 2025 and completion date of May 31, 2026. This Fast-Track Phase I/Phase II award supports the development and validation of a digital biomarker for amyotrophic lateral sclerosis (ALS)...
Impulse Wellness LLC received $305K in funding from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop the Bluetooth Electromyography-Based StrokeTherapeutic (BEST) System, an automated home-based stroke rehabilitation platform. The project, awarded July 1, 2026, with completion targeted for December 31, 2028, aims to design and validate a novel electromyography (EMG) muscular feedback rehabilitation system that integrates sensor-embedded textiles to deliver real-time biofeedback during therapeutic exercises. The system will feature reusable, fully embedded electrode technology tailored to specific targeted muscles and activities, representing an advancement over current single-use adhesive-based skin electrodes, with sensors built into garments to track muscle activity during dynamic movement. The BEST System addresses significant barriers to stroke rehabilitation by enabling high-quality, feedback-guided therapy accessible to patients in home settings, particularly underserved populations in rural or low-resource areas. With approximately 675,000 patients experiencing stroke annually and 8 million post-stroke individuals in the United States living with hemiparesis, the commercial potential targets a substantial market. The project's broader impact includes improved patient quality of life, reduced healthcare expenses, and expanded rehabilitation access by eliminating cost, distance, and service availability barriers that currently limit in-person rehabilitation participation.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $305.0k | 6/25/26 |